ViaLase
ViaLase, Inc. is a globally-minded, venture and strategic capital-backed, clinical stage medical technology company headquartered in Aliso Viejo, California, founded and led by Tibor Juhasz, PhD. The company develops the ViaLuxe Laser System, which combines femtosecond laser technology with micron-resolution OCT image guidance to perform femtosecond laser image-guided high-precision trabeculotomy (FLigHT) — a noninvasive, non-incisional procedure that creates drainage apertures through the trabecular meshwork to lower intraocular pressure in patients with open-angle glaucoma. The system pairs the ViaLuxe laser with the ViaLens patient interface and the ViaVue gonio camera. The company closed an approximately $40 million Series C financing in April 2024 with participation from Venture Investors Health Fund, Arboretum Ventures and Falcon Vision. The ViaLase Laser received CE Mark approval in the European Union in 2024 for adult patients with primary open-angle glaucoma and is under evaluation in a US IDE clinical trial; it is not approved for sale in the United States. ViaLase is a medical device manufacturer rather than a software vendor: it publishes no public API, developer portal, SDK, or machine-readable specification, and vialase.com is a WordPress marketing and clinical-education site.
ViaLase is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Healthcare, MedTech, and Ophthalmology.
ViaLase’s developer surface includes engineering blog and 6 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Commercial 1
Pricing, plans, and the legal terms of use
Company 4
The organization behind the API
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.